We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Waters (WAT) Expands TA Segment Offerings With New Solution
Read MoreHide Full Article
Waters (WAT - Free Report) introduced the Battery Cycler Microcalorimeter solution in a bid to strengthen its TA segment’s offerings.
Notably, the new solution is designed to collect six times more data and accelerate real-world testing from months to weeks.
The solution is capable of testing 12 batteries simultaneously for charge-discharge and thermal testing. Moreover, it supports the testing of three types of batteries namely coin, pouch and 18650 cylindrical.
The solution can also detect parasitic heat reactions quickly by integrating TAM IV Isothermal Microcalorimeter and TAM Assistant Software platform into BioLogic VSP-300 potentiostat.
We believe that the introduction of the Battery Cycler Microcalorimeter solution is expected to drive the company’s TA instruments business. This, in turn, will likely aid the performance of its TA operating segment.
In fourth-quarter 2022, the segment reported sales of $103.8 million (12% of net sales), which increased 10% year over year.
The latest move of the company positions it well to capitalize on the growth prospects in the battery cycler market.
Per a report from The Insights Partner, the global battery cycler market is expected to see a CAGR of 6.2% between 2022 and 2028.
We believe that Waters’ solid prospects in this promising market will contribute well to its financial performance in the days ahead. This, in turn, will continue helping it win investors’ confidence.
Coming to the price performance, WAT has lost 11.6% in the past year against the industry’s rally of 9.8%.
The Zacks Consensus Estimate for first-quarter 2023 sales is pegged at $695.5 million, indicating growth of 0.7% from the year-ago quarter’s reported quarter.
The consensus mark for earnings is projected at $2.60 per share, indicating a decline of 7.1% from the year-ago quarter’s reported figure of $2.80.
Expanding Portfolio
The latest move is in sync with Waters’ growing efforts toward expanding its product portfolio.
Apart from the latest launch, the company unveiled a Software-as-a-Service application called waters_connect System Monitoring, which is designed for high-volume quality assurance/quality control laboratories, wherein it can reduce the turnaround time of product release samples and facilitate the planning and progress of critical analyses.
WAT also launched Alliance iS, its next-generation intelligent HPLC System, which reduces common errors by up to 40%, manages operational risk, mitigates disruptions and increases overall productivity.
Additionally, Waters entered a definitive agreement to acquire Wyatt Technology for $1.36 billion in cash. With Wyatt, Waters' portfolio will expand and large molecule applications exposure will get a boost.
We believe that the company’s growing efforts toward strengthening its portfolio offerings will continue to drive its customer momentum, which, in turn, will benefit its financial performance.
Image: Bigstock
Waters (WAT) Expands TA Segment Offerings With New Solution
Waters (WAT - Free Report) introduced the Battery Cycler Microcalorimeter solution in a bid to strengthen its TA segment’s offerings.
Notably, the new solution is designed to collect six times more data and accelerate real-world testing from months to weeks.
The solution is capable of testing 12 batteries simultaneously for charge-discharge and thermal testing. Moreover, it supports the testing of three types of batteries namely coin, pouch and 18650 cylindrical.
The solution can also detect parasitic heat reactions quickly by integrating TAM IV Isothermal Microcalorimeter and TAM Assistant Software platform into BioLogic VSP-300 potentiostat.
We believe that the introduction of the Battery Cycler Microcalorimeter solution is expected to drive the company’s TA instruments business. This, in turn, will likely aid the performance of its TA operating segment.
In fourth-quarter 2022, the segment reported sales of $103.8 million (12% of net sales), which increased 10% year over year.
Waters Corporation Price and Consensus
Waters Corporation price-consensus-chart | Waters Corporation Quote
Growth Prospects
The latest move of the company positions it well to capitalize on the growth prospects in the battery cycler market.
Per a report from The Insights Partner, the global battery cycler market is expected to see a CAGR of 6.2% between 2022 and 2028.
We believe that Waters’ solid prospects in this promising market will contribute well to its financial performance in the days ahead. This, in turn, will continue helping it win investors’ confidence.
Coming to the price performance, WAT has lost 11.6% in the past year against the industry’s rally of 9.8%.
The Zacks Consensus Estimate for first-quarter 2023 sales is pegged at $695.5 million, indicating growth of 0.7% from the year-ago quarter’s reported quarter.
The consensus mark for earnings is projected at $2.60 per share, indicating a decline of 7.1% from the year-ago quarter’s reported figure of $2.80.
Expanding Portfolio
The latest move is in sync with Waters’ growing efforts toward expanding its product portfolio.
Apart from the latest launch, the company unveiled a Software-as-a-Service application called waters_connect System Monitoring, which is designed for high-volume quality assurance/quality control laboratories, wherein it can reduce the turnaround time of product release samples and facilitate the planning and progress of critical analyses.
WAT also launched Alliance iS, its next-generation intelligent HPLC System, which reduces common errors by up to 40%, manages operational risk, mitigates disruptions and increases overall productivity.
Additionally, Waters entered a definitive agreement to acquire Wyatt Technology for $1.36 billion in cash. With Wyatt, Waters' portfolio will expand and large molecule applications exposure will get a boost.
We believe that the company’s growing efforts toward strengthening its portfolio offerings will continue to drive its customer momentum, which, in turn, will benefit its financial performance.
Zacks Rank & Stocks to Consider
Currently, Waters carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader technology sector are Arista Networks (ANET - Free Report) , Salesforce (CRM - Free Report) and Analog Devices (ADI - Free Report) . Arista Networks and Salesforce sport a Zacks Rank #1 (Strong Buy), and Analog Devices carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Arista Networks shares have gained 27.4% in the past year. The long-term earnings growth rate for ANET is projected at 14.17%.
Salesforce shares have lost 9.1% in the past year. CRM’s long-term earnings growth rate is projected at 16.75%.
Analog Devices shares have gained 25.4% in the past year. The long-term earnings growth rate for ADI is projected at 12.25%.